Leadership & Pay ·
Prothena Chief Development Officer Chad Swanson resigns to join strategic partner
PRTAProthena Corp Public Ltd Co
Prothena Corporation plc announced that Chad J. Swanson, Ph.D., its Chief Development Officer, resigned effective October 9, 2026. Dr. Swanson is leaving to accept a position with one of the company's strategic partners, where he will assume a leadership role over a program partnered with Prothena. This executive departure involves key personnel and potential changes in clinical development oversight. The company operates in the biotechnology industry, focusing on the discovery and development of novel therapies for serious diseases.